2005
DOI: 10.1161/circulationaha.105.167586
|View full text |Cite|
|
Sign up to set email alerts
|

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
776
1
14

Year Published

2007
2007
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 1,971 publications
(798 citation statements)
references
References 755 publications
(600 reference statements)
7
776
1
14
Order By: Relevance
“…To evaluate trends after the 2005 and 2009 ACC/AHA guideline updates for the management of HF in adults,15, 16 we additionally evaluated trends in 3 intervals demarcated by the guideline‐release years (ie, 2001–2005, 2006–2009, and 2010–2014). Change in trend from one interval to the next (ie, between 2 adjoining intervals) was evaluated via piece‐wise regression modeling with robust variance.…”
Section: Methodsmentioning
confidence: 99%
“…To evaluate trends after the 2005 and 2009 ACC/AHA guideline updates for the management of HF in adults,15, 16 we additionally evaluated trends in 3 intervals demarcated by the guideline‐release years (ie, 2001–2005, 2006–2009, and 2010–2014). Change in trend from one interval to the next (ie, between 2 adjoining intervals) was evaluated via piece‐wise regression modeling with robust variance.…”
Section: Methodsmentioning
confidence: 99%
“…2005). The present etiology of HF is mainly associated with myocardial ischemia or infarction due to coronary artery diseases (Hunt et al.…”
Section: Introductionmentioning
confidence: 99%
“…The present etiology of HF is mainly associated with myocardial ischemia or infarction due to coronary artery diseases (Hunt et al. 2005). Ischemic HF occurs in more than 60% HF patients and leads to a high global burden (Moran et al.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1 Despite advances in pharmacologic therapy with angiotensin-converting enzyme inhibitors, β-blockers, and aldosterone antagonists, 2 -6 patients with HF account for over 12-15 million office visits and over 6.5 million hospital days each year. 7 Patients hospitalized for HF are at high risk for readmission, with a 6-mo readmission rate as high as 50%. 8 Studies show that comprehensive discharge planning, including medication counseling and review along with increased communication and follow-up, can help reduce readmissions.…”
Section: Introductionmentioning
confidence: 99%